Remove 2013 Remove Information Remove Pharmaceutical
article thumbnail

Building an Integrated, End-to-End R&D and Manufacturing Service Platform with Innovative R&D and High-end Preparation Technologies

Frost & Sullivan Manufacturing

Aligning with Industry Trends: Healthnice Advances Step by Step Amid the global pharmaceutical industry’s evolution, high-end preparations have become a mainstream trend in drug development. Therefore, for pharmaceutical companies, high-end preparations represent a high-value, cost-effective strategy for differentiation.

article thumbnail

How a top 10 pharma company tracks drug innovations and more with Feedly

Canadian Metalworking Magazine

Impact Curating relevant content for newsletters to inform recipients across the company Spending less than 1 hour daily on Feedly to select relevant insights Discovering and organizing open-source biopharma news in one place. Sienna is a Knowledge and Insights Advisor at a top 10 pharmaceutical company in Australia.

Sourcing 116
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Protecting the supply chain: Safeguarding against cyber vulnerabilities

Automation Mag

This includes integration of operational and information technology (OT/IT) in manufacturing as well as integration across businesses in the supply chain. Pharmaceutical, baked goods, vehicle production, chemicals and brewing industries are showing reliance on third parties. Growth in contract manufacturing amplifies the above risks.

article thumbnail

In tune with times, software application provider focuses on frontline workers

Control Engineering

Next Fadel served as a co-founder of ThingWorx, an application platform supplier for the connected world, serving as CEO and then president until its acquisition by PTC in 2013. The connected worker space emerged around 2012-2013. Connected-worker software gives each worker access to information. Courtesy: Augmentir.